PDA

View Full Version : Press Releases

  1. Nano Tech Hemostat!
  2. Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clin
  3. Blood clotting protein linked to rheumatoid arthritis
  4. Z-Medica now has retail products
  5. Hemo Concepts to Launch Integrated Blood Conservation Program At Texas Heart Institut
  6. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin...
  7. FDA Approves Sealant to Control Bleeding During Surgery
  8. Blood Transfusions May Be Harmful To Some Patients
  9. FDA Approves Voluven to Treat Serious Blood Volume Loss following Surgery
  10. Creighton University Medical Center Accredited by ABC.
  11. BBC article
  12. Bayer Stops Worldwide Sales of Trasylol Pending Safety Data
  13. FDA Approves Mircera: First Renal Anemia Treatment in the US with Monthly Maint...
  14. Bayer Yanks Aprotinin off the Market Pending Analysis of BART
  15. Synthetic Blood International's Oxycyte Featured on PBS' WIRED Science
  16. FDA Sides With CMS in EPO Battle; Labeling Change Next
  17. Medical Study Proves Claims of Natural Extract to Increase Circulating Stem Cells
  18. Stored blood lacks nitric oxide-Yahoo news
  19. Bloodless Cardiac Surgery in Jehovah's Witnesses: Outcomes Compared
  20. Biochip that guarantees safety in blood transfusions
  21. Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical
  22. Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
  23. A Recombinant EPO and Albumin Fusion
  24. Pre-operative Assessment - Jehovah’s Witnesses (UK Dept of Health)
  25. Anemic Children with Cancer Benefit from Erythropoietin
  26. Blood Avoidance Program Gives Families Options; DeVos Children's Hospital
  27. St. Vincent Healthcare Blood Conservation Program in the news!
  28. ALLIANCE PHARMA - April 20th/2006
  29. Akzo Nobel's Ferrazone iron compound receives FDA acceptance
  30. Alliance Pharmaceutical Corp. Reaches Agreement With Lender Committee.
  31. Hemo Concepts Contracts with Nebraska Methodist Hospital on Blood Conservation
  32. Hemosol has Filed a Notice of Intention to Make a Proposal to its Creditors
  33. Blood Conservation Strategies - Emory University Hospital Forum
  34. PolyHeme Trial to Begin Monday at Duke University Hospital
  35. Substituting blood transfusions
  36. Developing a 'Super'-EPO
  37. FDA Clears Novare's EndoLink(TM) Articulating Instruments for Marketing; Six Degrees
  38. Nuvelo Begins Phase 3 Trial of Alfimeprase for Acute Peripheral Arterial Occlusion, o
  39. MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(
  40. Bayer Initiates Phase III Clinical Study of Trasylol(R) Therapy During Primary Total
  41. Northfield Laboratories Inc. Announces Result of Third Interim Analysis of PolyHeme P
  42. REVLIMID(R) New Drug Application Submitted to FDA for Review
  43. ATS Medical to Participate in the American Association for Thoracic Surgery Meeting
  44. New Research Shows Three Innovative Nonsurgical Bone Tumor Treatments Provide Pain Re
  45. Nonsurgical Cryotherapy for Prostate Cancer, the 'Male Lumpectomy,' Preserves
  46. Biopure Completes Patient Enrollment in European Phase 2 Clinical Trial of Hemopure(R
  47. ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.
  48. Alliance Pharmaceutical Corp. and Beijing Double-Crane Pharmaceutical Co., Ltd. Annou
  49. Gish Cardiopulmonary Bypass Equipment Used in Pioneering Transfusion-free Surgery
  50. Transfusion-Free Surgery
  51. Physician response to conflicts between faith and medicine
  52. Heart attack patients who receive blood transfusions have higher death rate
  53. Vitamin B12 Taken Nasally Can Help Patients Starve off Anemia After Gastric Bypass
  54. Blood alternative reduces risk of disease
  55. New Innovative Non-Surgical Cardiac Procedure Provided at Trinitas: Elizabeth, NJ
  56. Haemonetics to Market First Non-Invasive Test for Blood Hematocrit
  57. ProMetic Announces that PRDT's Ligand Technology Binds and Removes Viruses from Blood
  58. Alternative blood salvage device to cell savers
  59. Ready System® 200 as an Alternative to the Traditional Heart Lung Machine and CABG
  60. Aggrastat(R), Added to Heparin, Reduced Complications From Unstable Angina
  61. No Need For Transfusions With New Blood Washer
  62. Biopure Receives FDA Response to Hemopure(R) Marketing Application
  63. U.S. FDA Finalizes Response Date for Biopure's Marketing Application of Hemopure
  64. Sangart Initiates Phase Ib/ii Clinical Trial For Hemospan(tm)
  65. Tissuelink Medical
  66. Tissuelink Medical Receives Fda Clearance For The Hemostatic Sealing And ...